Abstract PS10-14: Efficacy and safety of palbociclib (PAL) in patients (pts) with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) with preexisting conditions: A post hoc analysis of PALOMA-2
2019 ◽
2020 ◽
2016 ◽
Vol 4
(4)
◽
pp. 648-654
◽
2018 ◽
2020 ◽